Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0571-2026

Brand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot Activator Recall

Brand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot Activator Model/Catalog Number: 455071P Product Description: Greiner VACUETTE Blood Collection Tube with Clot Activator and Gel Separator and Standard Stopper (16 x 100 mm, 8ml)

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot Activator. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0571-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 19, 2025
FDA report date
Nov 26, 2025
Quantity in commerce
1,980,000
Distribution
See key details
FDA cause
Labeling Change Control

What is being recalled?

Brand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot Activator Model/Catalog Number: 455071P Product Description: Greiner VACUETTE Blood Collection Tube with Clot Activator and Gel Separator and Standard Stopper (16 x 100 mm, 8ml)

Affected model & UDI checker

Search the exact identifiers published for Z-0571-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
455071PBrand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot ActivatorCheck source noticeNot specified
Not specifiedBrand Name: Vacuette Product Name: 8 ml CAT Serum Separator Clot ActivatorCheck source notice29120017573061
FDA code information

Lot Code: Lot/Serial Numbers: Item# 455071P Lot# B250437N UDI-DI code: 29120017573061

View the original FDA recall notice

Why was this product recalled?

Some of the Vacuette¿ CAT Serum Separator Clot Activator tubes were manufactured without gel separator, which could yield erroneous assay results and require the patient to return to the lab for recollection or repeat testing. This may result in delayed diagnosis, cause a delay in clinical decision-making or treatment and in some rare cases, yield incorrect results from less stable parameters.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Greiner Bio-One North America, Inc. take?

On 08/22/2025, the firm sent via email an "Urgent Medical Device Correction" letter to customer informing them that some Vacuette CAT Serum Separator Clot Activator tubes were manufactured without gel separator which may affect the stability of the sample. Customers are instructed to: " Stop use immediately: Discontinue use of the affected product (concerned Item/Lot) and isolate it within your facility. " Notify staff and customers: Inform all relevant employees and notify all customers to whom you distributed the affected products. " Assess risk: Evaluate potential risks or consequences in accordance with your internal procedures and take appropriate action. " Confirm product disposition: Complete the attached Product Disposition Site Confirmation Form and return it via fax to 877-217-7927 or email to recalls.us@gbo.com. Confirmation is required that all affected products have been discarded/destroyed. Replacement products will be provided upon receipt of your completed form. For questions, call Greiner Bio-One Technical Service at 800-515-8112.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology